RxDoctor Payments Data

David Deibert

Endocrinology, Diabetes & Metabolism · Wyomissing, PANPI 1528119955

Payments from drug & device makers

$3,313in general payments, 2019–2025

Across 252 payments — averaging $13.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$724
  • AbbVie$653
  • Amarin Pharma, Inc.$492
  • Abbott$212
  • Novo Nordisk$184
  • Merck$152
  • plus $896 from 14 others

What the payments were for

  • Food & beverage$3,308100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,313 in reported general payments places this provider in the 60th percentile of 388 endocrinology, diabetes & metabolism providers in Pennsylvania.

See all endocrinology, diabetes & metabolism providers in Pennsylvania

Other endocrinology, diabetes & metabolism in Wyomissing

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →